These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23869440)

  • 1. Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection model.
    Takemura-Uchiyama I; Uchiyama J; Kato S; Inoue T; Ujihara T; Ohara N; Daibata M; Matsuzaki S
    FEMS Microbiol Lett; 2013 Oct; 347(1):52-60. PubMed ID: 23869440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silkworm larvae as an animal model of bacterial infection pathogenic to humans.
    Kaito C; Akimitsu N; Watanabe H; Sekimizu K
    Microb Pathog; 2002 Apr; 32(4):183-90. PubMed ID: 12079408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Silkworm Larva Model in Phage Therapy Experiments.
    Uchiyama J; Takemura-Uchiyama I; Matsuzaki S
    Methods Mol Biol; 2019; 1898():173-181. PubMed ID: 30570732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-component signaling in the virulence of Staphylococcus aureus: a silkworm larvae-pathogenic agent infection model of virulence.
    Kurokawa K; Kaito C; Sekimizu K
    Methods Enzymol; 2007; 422():233-44. PubMed ID: 17628142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents.
    Desbois AP; Coote PJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1785-90. PubMed ID: 21622972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of propagation processes of Staphylococcus aureus bacteriophages S13' and S25-3 in two different taxonomies by definitive screening design.
    Takeuchi I; Nasukawa T; Sugimoto R; Takemura-Uchiyama I; Murakami H; Uchiyama J
    Virus Res; 2021 Jun; 298():198406. PubMed ID: 33798676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental phage therapy against lethal lung-derived septicemia caused by Staphylococcus aureus in mice.
    Takemura-Uchiyama I; Uchiyama J; Osanai M; Morimoto N; Asagiri T; Ujihara T; Daibata M; Sugiura T; Matsuzaki S
    Microbes Infect; 2014 Jun; 16(6):512-7. PubMed ID: 24631574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.
    Matsuzaki S; Yasuda M; Nishikawa H; Kuroda M; Ujihara T; Shuin T; Shen Y; Jin Z; Fujimoto S; Nasimuzzaman MD; Wakiguchi H; Sugihara S; Sugiura T; Koda S; Muraoka A; Imai S
    J Infect Dis; 2003 Feb; 187(4):613-24. PubMed ID: 12599078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico analysis of AHJD-like viruses, Staphylococcus aureus phages S24-1 and S13', and study of phage S24-1 adsorption.
    Uchiyama J; Takemura-Uchiyama I; Kato S; Sato M; Ujihara T; Matsui H; Hanaki H; Daibata M; Matsuzaki S
    Microbiologyopen; 2014 Apr; 3(2):257-70. PubMed ID: 24591378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Bombyx mori larvae as a surrogate animal model for evaluation of the anti-infective potential of oxazolidinones.
    Barman TK; Arora P; Rao M; Bhadauriya T; Upadhyay DJ
    J Infect Chemother; 2008 Apr; 14(2):166-9. PubMed ID: 18622683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L; Benhar I
    Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1.
    Jun SY; Jung GM; Yoon SJ; Oh MD; Choi YJ; Lee WJ; Kong JC; Seol JG; Kang SH
    Int J Antimicrob Agents; 2013 Feb; 41(2):156-61. PubMed ID: 23276502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of therapeutic effects and pharmacokinetics of antibacterial chromogenic agents in a silkworm model of Staphylococcus aureus infection.
    Fujiyuki T; Imamura K; Hamamoto H; Sekimizu K
    Drug Discov Ther; 2010 Oct; 4(5):349-54. PubMed ID: 22491238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant
    Xu Y; Yang T; Miao Y; Zhang Q; Yang M; Mao C
    ACS Appl Mater Interfaces; 2024 Apr; 16(14):17232-17241. PubMed ID: 38554078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a Myoviridae bacteriophage against Staphylococcus aureus isolated from dairy cows with mastitis.
    Han JE; Kim JH; Hwang SY; Choresca CH; Shin SP; Jun JW; Chai JY; Park YH; Park SC
    Res Vet Sci; 2013 Oct; 95(2):758-63. PubMed ID: 23790669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lytic Staphylococcus aureus bacteriophage against multidrug-resistant Staphylococcus aureus in mice.
    Oduor JM; Onkoba N; Maloba F; Arodi WO; Nyachieo A
    J Infect Dev Ctries; 2016 Nov; 10(11):1208-1213. PubMed ID: 27886033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination utility of phages GH15 and K against Staphylococcus aureus].
    Liu X; Gu J; Han W; Li Y; Han D; Zhang Q; Lu R; Song J; Feng X; Lei L
    Wei Sheng Wu Xue Bao; 2013 May; 53(5):498-506. PubMed ID: 23957155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Presence of Two Receptor-Binding Proteins Contributes to the Wide Host Range of Staphylococcal Twort-Like Phages.
    Takeuchi I; Osada K; Azam AH; Asakawa H; Miyanaga K; Tanji Y
    Appl Environ Microbiol; 2016 Oct; 82(19):5763-74. PubMed ID: 27422842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Response to Therapeutic Staphylococcal Bacteriophages in Mammals: Kinetics of Induction, Immunogenic Structural Proteins, Natural and Induced Antibodies.
    Kaźmierczak Z; Majewska J; Miernikiewicz P; Międzybrodzki R; Nowak S; Harhala M; Lecion D; Kęska W; Owczarek B; Ciekot J; Drab M; Kędzierski P; Mazurkiewicz-Kania M; Górski A; Dąbrowska K
    Front Immunol; 2021; 12():639570. PubMed ID: 34194425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental phage therapy against Staphylococcus aureus in mice.
    Capparelli R; Parlato M; Borriello G; Salvatore P; Iannelli D
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2765-73. PubMed ID: 17517843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.